Lorcaserin Extended-Release Tablets and Rifadin IV Intravenous
Determining the interaction of Lorcaserin Extended-Release Tablets and Rifadin IV Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lorcaserin
Brand name: Belviq, Belviq XR
Synonyms: Lorcaserin
Generic Name: rifampin
Brand name: Rifadin IV, Rifadin, Rimactane
Synonyms: Rifadin IV (Intravenous), Rifadin IV
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lorcaserin Extended-Release Tablets-Rifamate
- Lorcaserin Extended-Release Tablets-Rifampin
- Lorcaserin Extended-Release Tablets-Rifampin and Isoniazid
- Lorcaserin Extended-Release Tablets-Rifampin Capsules
- Lorcaserin Extended-Release Tablets-Rifampin Injection
- Lorcaserin Extended-Release Tablets-Rifampin Intravenous
- Rifadin IV Intravenous-Lorcaserin Hydrochloride
- Rifadin IV Intravenous-Lorcaserin Tablets
- Rifadin IV Intravenous-Lorcet
- Rifadin IV Intravenous-Lorcet Plus
- Rifadin IV Intravenous-Lorcet Tablets
- Rifadin IV Intravenous-Lorlatinib